By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Feb 27, 2024
Vicente LLP shares a high-level overview of the first draft rules for Colorado's regulated natural medicine market. These draft rules focus on facilitator qualifications, education requirements, and training programs.
.png)
By David M. Ullian
Feb 26, 2024
Washington, D.C. will soon be accepting applications for new medical cannabis retail licenses. The application process is divided into two periods, with Social Equity Applicants getting priority and an earlier application window. This blog details the two available license types, eligibility requirements, and the application process. Additionally, it outlines new enforcement actions against unlicensed I-71 cannabis “gifting” businesses.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Feb 15, 2024
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #8.1 gives context to the 123 recommendations which will form the basis of the regulated nature medicine program approved by Colorado voters in November 2022.
By Colleen Mitchell
Feb 14, 2024
Missouri's cannabis market is expanding rapidly, offering a new opportunity for microbusinesses. The state plans to issue 48 microbusiness licenses in summer 2024, allowing smaller players to enter the cultivation, processing, and dispensary sectors. However, applications are competitive and require careful preparation, including team building, business formation, and real estate acquisition. This Insights post provides key details about the licensing process and eligibility criteria.
By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Feb 14, 2024
Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #8 focuses on updates on the NMAB's initial set of recommendations for the state’s regulated natural medicine program
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.